Literature DB >> 12749958

Tricyclic antidepressants as long-acting local anesthetics.

Yukari Sudoh1, Elaine Elliott Cahoon, Peter Gerner, Ging Kuo Wang.   

Abstract

Amitriptyline, nortriptyline, imipramine, doxepin, desipramine, protriptyline, trimipramine, and maprotiline are tricyclic antidepressants (TCAs) used orally in treating major depressive disorders. Recent studies showed that amitriptyline is more potent in blocking the sciatic nerve functions in vivo by local injection than bupivacaine, a long-acting local anesthetic. We therefore tested whether various TCAs could likewise act as local anesthetics in vivo after single injection via the rat sciatic notch. The duration of complete sciatic nerve blockade by TCAs and the time to reach full recovery were measured with neurobehavioral assays and compared with results from bupivacaine. Amitriptyline, doxepin, and imipramine at 5mM elicited a longer complete sciatic nerve blockade than did bupivacaine at 15.4mM (0.5%), whereas trimipramine and desipramine at 5mM produced a shorter blockade. In contrast, nortriptyline, protriptyline, and maprotiline failed to elicit complete sciatic nerve blockade. Thus, TCAs have very different efficacy as local anesthetics in vivo. The duration of rat sciatic nerve blockade in vivo by TCAs is not well correlated with the 50% inhibitory concentration (IC(50)) of TCAs in blocking human cardiac Nav1.5 Na(+) channels expressed in human embryonic kidney cells. With this in vitro expression system, TCAs appear more potent than bupivacaine as Na(+) channel blockers in Nav1.5 Na(+) channels. We suggest that the ability of TCAs to pass through various membrane barriers within peripheral nerve trunks is crucial to their local anesthetic efficacy in vivo. TCAs with a tertiary amine appear more effective in penetrating these membrane barriers than TCAs with a secondary amine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749958     DOI: 10.1016/s0304-3959(02)00375-5

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  22 in total

1.  The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats.

Authors:  Ercan Ozdemir; Sinan Gursoy; Ihsan Bagcivan
Journal:  J Physiol Sci       Date:  2012-04-29       Impact factor: 2.781

Review 2.  Pharmacologic therapies for complex regional pain syndrome.

Authors:  Sean Mackey; Steven Feinberg
Journal:  Curr Pain Headache Rep       Date:  2007-02

3.  Rapid colorimetric screening of drug interaction and penetration through lipid barriers.

Authors:  Marina Katz; Izek Ben-Shlush; Sofiya Kolusheva; Raz Jelinek
Journal:  Pharm Res       Date:  2006-03-06       Impact factor: 4.200

Review 4.  Antidepressants as analgesics.

Authors:  Gary McCleane
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  Beneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemia.

Authors:  Che-Chuan Wang; Chung-Ching Chio; Ching-Hong Chang; Jinn-Rung Kuo; Ching-Ping Chang
Journal:  BMC Pharmacol       Date:  2010-09-06

6.  Blockade of Nav1.8 currents in nociceptive trigeminal neurons contributes to anti-trigeminovascular nociceptive effect of amitriptyline.

Authors:  Jingyao Liang; Xiaoyan Liu; Meiyan Pan; Wei Dai; Zhao Dong; Xiaolin Wang; Ruozhuo Liu; Jianquan Zheng; Shengyuan Yu
Journal:  Neuromolecular Med       Date:  2013-11-30       Impact factor: 3.843

Review 7.  Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org).

Authors:  Pieter G Postema; Christian Wolpert; Ahmad S Amin; Vincent Probst; Martin Borggrefe; Dan M Roden; Silvia G Priori; Hanno L Tan; Masayasu Hiraoka; Josep Brugada; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2009-07-08       Impact factor: 6.343

8.  Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia.

Authors:  Srinivasa M Sammeta; Siva Ram K Vaka; S Narasimha Murthy
Journal:  J Control Release       Date:  2009-11-14       Impact factor: 9.776

Review 9.  Antidepressants for the treatment of chronic pain.

Authors:  Bénédicte Verdu; Isabelle Decosterd; Thierry Buclin; Friedrich Stiefel; Alexandre Berney
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  Serotonin in pain and analgesia: actions in the periphery.

Authors:  Claudia Sommer
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.